The importance of active STAT3 in TNBC has been recently unveiled by Nakagawa and colleagues [36], who reported that the nuclear expression of pSTAT3 was significantly associated with short relapse-free survival and a poor prognosis in TNBC patients, but not in ER(+) breast cancer women. This evidence concerns the gene ESR1 and breast carcinoma.